Show simple item record

dc.contributor.authorSafdari, Y
dc.contributor.authorAhmadzadeh, V
dc.contributor.authorKhalili, M
dc.contributor.authorJaliani, HZ
dc.contributor.authorZarei, V
dc.contributor.authorErfani-Moghadam, V
dc.date.accessioned2018-08-26T07:41:05Z
dc.date.available2018-08-26T07:41:05Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47398
dc.description.abstractSingle-chain antibodies (scFvs), which contain only the variable domains of full-length antibodies, are relatively small molecules that can be used for selective drug delivery. In this review, we discuss how scFvs help improve the specificity and efficiency of drugs. Small interfering RNA (siRNA) delivery using scFv-drug fusion peptides, siRNA delivery using scFv-conjugated nanoparticles, targeted delivery using scFv-viral peptide-fusion proteins, use of scFv in fusion with cell-penetrating peptides for effective targeted drug delivery, scFv-mediated targeted delivery of inorganic nanoparticles, scFv-mediated increase of tumor killing activity of granulocytes, use of scFv for tumor imaging, site-directed conjugation of scFv molecules to drug carrier systems, use of scFv to relieve pain and use of scFv for increasing drug loading efficiency are among the topics that are discussed here.
dc.language.isoEnglish
dc.relation.ispartofMOLECULAR MEDICINE
dc.titleUse of Single-Chain Antibody Derivatives for Targeted Drug Delivery
dc.typeArticle
dc.citation.volume22
dc.citation.spage258
dc.citation.epage270
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.2119/molmed.2016.00043


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record